ArticleFoods (Basel, Switzerland)2026
Systematic Identification of Characteristic Metabolites and Analysis of Quality and Metabolomic Profiles of Yunnan Kucha White Tea.
Article in Foods (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Kucha, a unique tea germplasm rich in theacrine, imparts its fresh leaves with a particularly bitter taste and multiple bioactivities. However, systematic studies on processed Kucha-especially white tea-remain limited. In this study, white teas were produced from two Yunnan Kucha accessions (YLKC1, YLKC2) and two conventional cultivars. Their quality characteristics and non-volatile metabolic profiles were systematically compared using sensory evaluation, targeted quantification and widely targeted metabolomics. Results indicated that Kucha white teas displayed pronounced bitterness, with YLKC1 presenting a richer, well-layered flavor, indicating promising quality potential. Targeted quantification demonstrated a remarkably high theacrine content (~30 mg/g) in Kucha white teas, whereas caffeine and several catechin monomers were significantly lower than those in conventional cultivars. Widely targeted metabolomic analysis identified 3376 non-volatile metabolites. PCA and OPLS-DA demonstrated a clear separation in metabolic profiles between Kucha and control groups. In total, 601 significantly differential metabolites were identified. Taste-driven annotation against ChemTastesDB revealed 17 known bitter compounds, 10 of which were significantly accumulated in Kucha white tea-including theacrine, theophylline, theobromine, L-arginine, neohesperidin, pinocembrin, kaempferol-3-O-(6"-malonyl)glucoside, fraxin, adenosine, and xanthine. Among these compounds, theacrine showed the highest upregulation (9.30-fold). In addition, several galloylated flavonoid glycosides also exhibited significant accumulation. KEGG enrichment analysis further indicated that flavonoid biosynthesis and caffeine metabolism were crucial pathways contributing to these metabolic differences. Collectively, these findings demonstrate that the characteristic bitterness of Kucha white tea arises from the coordinated accumulation of a specific set of bitter phytochemicals rather than a single compound and provide a prioritized panel of candidate compounds for flavor-oriented breeding and processing.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.